Silence Therapeutics (SLNCF) Receivables Refunds (2019 - 2024)
Historic Receivables Refunds for Silence Therapeutics (SLNCF) over the last 6 years, with Q4 2024 value amounting to $1.5 million.
- Silence Therapeutics' Receivables Refunds fell 9296.09% to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year decrease of 9296.09%. This contributed to the annual value of $1.5 million for FY2024, which is 2369.48% up from last year.
- Silence Therapeutics' Receivables Refunds amounted to $1.5 million in Q4 2024, which was down 9296.09% from $21.9 million recorded in Q4 2023.
- Silence Therapeutics' 5-year Receivables Refunds high stood at $21.9 million for Q4 2023, and its period low was $1.5 million during Q4 2024.
- Over the past 5 years, Silence Therapeutics' median Receivables Refunds value was $9.4 million (recorded in 2021), while the average stood at $11.0 million.
- Its Receivables Refunds has fluctuated over the past 5 years, first skyrocketed by 10042.53% in 2021, then tumbled by 9296.09% in 2024.
- Over the past 5 years, Silence Therapeutics' Receivables Refunds (Quarter) stood at $4.7 million in 2020, then skyrocketed by 100.43% to $9.4 million in 2021, then soared by 86.32% to $17.5 million in 2022, then grew by 25.33% to $21.9 million in 2023, then tumbled by 92.96% to $1.5 million in 2024.
- Its Receivables Refunds stands at $1.5 million for Q4 2024, versus $21.9 million for Q4 2023 and $17.5 million for Q4 2022.